2-Bromo-5-chloropyridine-3-carbonitrile, 95+%, 500mg

3-(4-(Trifluoromethyl)phenyl)acrylaldehyde, 95.0%, 250mg

2,4-Bis(4-(tert-butyl)phenyl)-6-chloro-1,3,5-triazine, 98%, 1g

(E)-3-(1H-IMIDAZOL-5-YL)ACRYLIC ACID, 95%, 100mg

2-Pyrrolidone, min. 99.5%, for synthesis, 2.5 l, plastic packaging.

Di(piperidin-4-yl)methane dihydrochloride, 98%, 100mg

2-Bromo-6-chloro-4-nitroaniline>98.0%(GC)25g

4-Benzyl 1-tert-butyl 2-methyl piperazine-1,2,4-tricarboxylate, 97%, 1g

tert-Butyl 4-(hydroxymethyl)-3-isopropyl-3,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridine-5-carboxylate, 97%, 500mg

Ledipasvir acetone, 99.76%, 5mg

(R)-3-(1-Aminoethyl)-4-fluorobenzonitrile, 98%, 5g

Methyl 5-iodopicolinate, 97.0%, 5g

(+/-)-3-Amino-homopiperidine, 99.0%, 5g